JPRN-jRCTs051180239已完成未知
Clinical and neuroimaging study on preclinical Alzheimer's disease. - AMED Preclinical study
Shimada Hiroyuki0 个研究点目标入组 40 人开始时间: 2019年3月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
Psychological tests, amyloid PET, MRI tests, and biochemical tests were performed on 40 registered subjects (25 males, 15 females, average age 74 years (65-83 years)). There were 3 preclinical ADs, 12 MCIs (7 early MCIs and 5 late MCIs), and 25 healthy individuals. These subjects were followed up every 12 months for up to 36 months.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 60age old 至 < 85age old（—）
- 性别
- All
入选标准
- •Subjects at the preclinical AD stage
排除标准
- •Patients with dementia
研究者
相似试验
已完成
不适用
Clinical and neuroimaging study on preclinical Alzheimer's disease.mild cognitive impairment, preclinical Alzheimer diseaseJPRN-UMIN000019926Osaka City University40
已完成
不适用
Alzheimers Disease and Neuromarkers in Patients With Acute Hip FracturesAlzheimers DiseaseInflammationHip FractureNCT02409082Sahlgrenska University Hospital, Sweden400
暂停
1 期
Positron Emission Tomography of Amyloid in Alzheimer's DiseaseAlzheimer's DiseaseNCT00205621Amsterdam UMC, location VUmc50
已完成
不适用
Effects of Transcranial Magnetic Stimulation (TMS) and Cognitive Training for Alzheimer PatientsAlzheimer Disease, Early OnsetNCT00909285Assaf-Harofeh Medical Center20
招募中
不适用
Imaging Biomarkers in Preclinical and Symptomatic ADAlzheimer DiseaseNCT04134923Tammie L. S. Benzinger, MD, PhD375